About AeroRx Therapeutics
AeroRx Therapeutics is a private company based in LA Jolla, California, incorporated in 2024 in Delaware. It has reported $10,376,003 raised in one offering on Form D since October 2025. Its chief executive is Ahmet Tutuncu, M.D., Ph.D..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 2025 | Oct 10, 2025 | $10,376,003of $20.7M target | 17 | $610K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AeroRx Therapeutics's Form D filed Oct 10, 2025.
AD
Ahmet Tutuncu, M.D., Ph.D.
Chief Executive Officer and director
TR
Tighe Reardon
Executive officer
Also an executive officer and director at AristaMD and an executive officer at Enlaza Therapeutics.
HD
Heather Preston, M.D.
Director
JD
Jay Lichter, Ph.D.
Director
JD
John Patton, Ph.D.
Director
SD
Sanford Madigan, Ph.D.
Director